The Wayback Machine - https://web-wp.archive.org/web/20250502164211/https://www.nejm.org/about-nejm/permissions
Skip to main content
|Create Account
Subscribe
The New England Journal of Medicine homepage
Advanced Search

Permissions & Licensing

Submit Your Permission Request Using RightsLink

For permission to reuse content from the New England Journal of Medicine (NEJM), visit NEJM.org and locate the article or video from which you seek to reuse content.

Once you have located and accessed the article you are looking for on NEJM.org:

  • Click on the Permissions link © in the toolbar above the abstract
  • Follow the prompts to select the options that best suit your needs
  • The system will either provide you with an immediate price quote or will place your request in a queue for Publisher review, sometimes requiring additional information
  • When prompted to continue, either sign in to your existing RightsLink account, or create a new account if you do not already have one and follow the additional prompts to secure permission

If you have questions about using the RightsLink service, please contact: [email protected].

For general questions about NEJM Group Permissions, email: [email protected].

NEJM Group Commercial Use Guidelines

NEJM Group products include the New England Journal of Medicine, NEJM Evidence, NEJM Catalyst, NEJM Journal Watch, NEJM AI, and NEJM Yi Xue Qian Yan. NEJM Group is a division of the Massachusetts Medical Society.

NEJM Group content is protected by copyright. While many NEJM Group content items such as articles, figures, tables, videos, and podcasts are free online, NEJM Group content is for personal, non-commercial use in accordance with copyright law.

The following uses require permission from NEJM Group:

  • Copying or downloading of content for redistribution by a commercial organization
  • The inclusion or incorporation of content in other works or services (other than normal quotations with an appropriate citation) that are made available by a commercial organization for informational or educational purposes
  • Use of content (other than normal quotations with appropriate citation) for marketing and promotional purposes
  • Linking directly to content by commercial organizations
  • The distribution of content in any form

For information regarding NEJM Group permissions, please contact [email protected].

For information regarding NEJM Group reprints, please contact [email protected].

Permission for Authors

If you are the author of an article that has been published in NEJM, see Author Permissions.

Note: All commercial reuse examples discussed in section above also apply to authors of NEJM Group manuscripts that are employed by industry and distributing/exposing content on behalf of their employers.

NEJM Group Licensing & Licensing for AI

The New England Journal of Medicine (NEJM) is recognized as the world’s leading medical journal, our mission is to publish the best research and information at the intersection of biomedical science and clinical practice and to present this information in understandable, clinically useful formats that inform health care practice and improve patient outcomes.

Fulfilling this ambitious promise requires teamwork. NEJM Group’s Licensing programs help to serve our mission through collaboration that makes our information more useful and effective to medical professionals around the world.

3rd PartyLicensing – NEJM Group works with 3rd parties to:

  • make our more discoverable and extend our reach to broader audiences.
  • improve information products through the inclusion of NEJM Group content.
  • enhance healthcare related applications with research and evidence that support clinician decision making.

To Learn more about our Licensing programs please contact: [email protected].

Industry Sponsored Research and Engagement – NEJM works with pharmaceutical and life science companies to support their clinician engagement programs by providing sponsored access to NEJM Group publications.

To Learn more about our Sponsored Research and Engagement programs contact: [email protected].

AI and LLM initiatives

Artificial Intelligence and Large Language Models can help researchers and clinicians in many ways. NEJM Group offers programs that enables our research to support:

  • Institutional Research and Internal Application Development.
  • Commercial applications for health-related products.
  • Train commercial LLM’s to improve and extend the quality of datasets

To learn more about our AI programs please contact: [email protected].

Reuse of Content Within a Thesis or Dissertation

Content (full-text or portions thereof) may be used in print and electronic versions of a dissertation or thesis without formal permission from the Massachusetts Medical Society (MMS), Publisher of the New England Journal of Medicine.

The following credit line must be printed along with the copyrighted material:

Reproduced with permission from (scientific reference citation), Copyright Massachusetts Medical Society.

Third-Party Content

Grants of permissions apply only to copyrighted materials that the MMS owns and not to copyrighted texts or illustrations from other sources.

Prohibited Uses

The New England Journal of Medicine (and its logo design) are registered trademarks of the Massachusetts Medical Society. NEJM does not grant permission for its logo, cover, or brand identity to be used in materials. Permission will not be granted for photographs depicting identifiable individuals. Altering a photograph to anonymize an individual is not permitted.